CLRB Company Profile and Key Details

Q: Who are the executives of CLRB?

Mr. Jarrod LongcorChief Operating OfficerMr. Darrell Shane LeaChief Commercial OfficerMr. Shane LeaChief Commercial OfficerMr. Andrei Shustov M.D.Senior Vice President of MedicalMr. James V. CarusoPres, Chief Executive Officer & DirectorMr. Chad J. Kolean C.P.A., CPAVice President, Chief Financial Officer & Sec.Dr. Andrei Shustov M.D.Senior Vice President of MedicalMr. Chad J. Kolean CPA, CPAVice President, Chief Financial Officer & Sec.

NASDAQ : CLRB

Cellectar Biosciences

$2.55

-0.03-1.16%

Open: 9:51 AM

63.16

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Cellectar Biosciences, Inc. (CLRB) stock declined over -1.16%, trading at $2.55 on NASDAQ, down from the previous close of $2.58. The stock opened at $2.54, fluctuating between $2.54 and $2.55 in the recent session.

Stock Snapshot

2.58

Prev. Close

8.14M

Market Cap

2.54

Day Low

-0.38

P/E Ratio

-6.66

EPS (TTM)

-1.79

Cash Flow per Share

2.54

Open

3.19M

Number of Shares

2.5543

Day High

94.33%

Free Float in %

-0.07

Book Value

9.25K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 21, 2026	2.53	2.63	2.52	2.58	17.85K
Jul 20, 2026	2.51	2.55	2.48	2.52	13.62K
Jul 17, 2026	2.52	2.59	2.47	2.51	50.49K
Jul 16, 2026	2.56	2.64	2.50	2.58	45.9K
Jul 15, 2026	2.58	2.82	2.51	2.61	787.5K
Jul 14, 2026	2.65	2.78	2.63	2.63	44.28K
Jul 13, 2026	2.81	2.84	2.61	2.63	133.25K
Jul 10, 2026	2.80	2.87	2.71	2.82	65.67K
Jul 09, 2026	2.80	2.81	2.67	2.77	17.53K
Jul 08, 2026	2.70	2.70	2.60	2.69	25.6K
Jul 07, 2026	2.80	2.80	2.60	2.70	26.34K
Jul 06, 2026	2.80	2.86	2.66	2.77	30.99K
Jul 02, 2026	2.85	3.02	2.77	2.81	26.22K
Jul 01, 2026	2.79	2.89	2.70	2.83	92.15K
Jun 30, 2026	2.59	3.08	2.55	2.78	415.58K
Jun 29, 2026	2.58	2.70	2.52	2.60	184.61K
Jun 26, 2026	2.48	2.54	2.47	2.52	11.27K
Jun 25, 2026	2.53	2.59	2.46	2.47	78.77K
Jun 24, 2026	2.50	2.57	2.46	2.49	37.29K
Jun 23, 2026	2.51	2.66	2.50	2.50	59.41K

Contact Details

Florham Park, NJ 07932

United States

https://www.cellectar.com 608 441 8120

About Company

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemotherapeutic program, which is in preclinical stages with the aim of treating solid tumors. The firm also participates in collaborative PDC development initiatives with partners such as Avicenna Oncology GMBH for the CLR 2000 Series, Orano Med for the CLR 12120 Series, as well as IntoCell Inc. and LegoChemBio. Established in 2002, Cellectar Biosciences maintains its corporate headquarters in Florham Park, New Jersey.

Stock Peers

ARGX

28.55+3.37%

argenx SE$874.74 REGN

3.04+0.45%

Regeneron Pharmaceuticals, Inc.$675.19 MDGL

11.1+2.07%

Madrigal Pharmaceuticals, Inc.$546.79 UTHR

6.49+1.23%

United Therapeutics Corporation$535.83 VRTX

1.5+0.31%

Vertex Pharmaceuticals Incorporated$482.00 KRYS

-0.16-0.05%

Krystal Biotech, Inc.$339.06 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

8.11+2.61%

BeOne Medicines AG$318.69 PRAX

13.44+4.41%

Praxis Precision Medicines, Inc.$317.87 LGND

11.48+3.90%

Ligand Pharmaceuticals Incorporated$305.47

Frequently Asked Questions

What is the current Cellectar Biosciences, Inc. (CLRB) stock price?

Cellectar Biosciences, Inc. (NASDAQ: CLRB) stock price is $2.55 in the last trading session. During the trading session, CLRB stock reached the peak price of $2.55 while $2.54 was the lowest point it dropped to. The percentage change in CLRB stock occurred in the recent session was -1.16% while the dollar amount for the price change in CLRB stock was - $0.03.

CLRB's industry and sector of operation?

The NASDAQ listed CLRB is part of Biotechnology industry that operates in the broader Healthcare sector. Cellectar Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLRB?

Mr. Jarrod Longcor
Chief Operating Officer
Mr. Darrell Shane Lea
Chief Commercial Officer
Mr. Shane Lea
Chief Commercial Officer
Mr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. James V. Caruso
Pres, Chief Executive Officer & Director
Mr. Chad J. Kolean C.P.A., CPA
Vice President, Chief Financial Officer & Sec.
Dr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. Chad J. Kolean CPA, CPA
Vice President, Chief Financial Officer & Sec.

How CLRB did perform over past 52-week?

CLRB's closing price is 17.27% higher than its 52-week low of $2.20 where as its distance from 52-week high of $6.52 is -60.43%.

How many employees does CLRB have?

Number of CLRB employees currently stands at 11.

Link for CLRB official website?

Official Website of CLRB is: https://www.cellectar.com

How do I contact CLRB?

CLRB could be contacted at phone 608 441 8120 and can also be accessed through its website. CLRB operates from 100 Campus Drive, Florham Park, NJ 07932, United States.

How many shares of CLRB are traded daily?

CLRB stock volume for the day was 9.25K shares. The average number of CLRB shares traded daily for last 3 months was 1.09M.

What is the market cap of CLRB currently?

The market value of CLRB currently stands at $8.14M with its latest stock price at $2.55 and 3.19M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	11
Beta	0.55
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	11
Beta	0.55
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CLRB Company Profile and Key Details

Cellectar Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics